Send to

Choose Destination
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):280-6. doi: 10.5507/bp.2016.011. Epub 2016 Mar 24.

Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study.

Author information

Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Department of Surgery I, University Hospital Olomouc, Czech Republic.
Department of Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.



To analyse the 5-year survival rate of patients undergoing radical surgery for pancreatic ductal adenocarcinoma (PDAC) and to identify prognostic factors.


A prospectively maintained database of 90 consecutive patients who underwent radical resection for PDAC was analysed. Survival was evaluated using the Kaplan-Meier method. Log-rank test and Cox regression analysis were used for the evaluation of prognostic factors. P values less than 0.05 were considered significant.


Mean age (± standard deviation) was 63.2±8.6 years (female 28.9% and male 71.1%). Tumour localisation was in the head in 76 (84.5%), multifocal in 3 (3.3%) and in the body/tail in 11 (12.2%). Pancreatic head resection was performed in 75 (83.3%), total pancreatectomy in 4 (4.4%) and distal pancreatectomy with splenectomy in 11 (12.2%), with standard lymphadenectomy. Venous resection was in 4 (4.4%). Thirty-day and in-hospital mortality occurred in 1 (1.1%), 90-day mortality was 3.3%. On univariate analysis absence of perineural and vascular invasion, stage, absence of lymph node infiltration and no need for transfusion were associated with improved overall survival. On multivariate analysis vascular invasion HR=3.137 (95%CI: 1.692-5.816; P = 0.0003) and postoperative complications HR=2.004 (95%CI: 1.198-3.354; P = 0.008) were identified as significant independent predictors of survival. The five-year survival rate was 18.9%, with five-year recurrence-free survival of 16.7%.


Vascular invasion and postoperative complications were independent prognostic factors after curative resections of pancreatic cancer in studied cohort.


complications; long term survival; pancreatic ductal adenocarcinoma; surgical therapy

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Palacky University Olomouc
Loading ...
Support Center